Cytek Biosciences

CTKB61

$6.55arrow_drop_up1.47%$0.09

CTKB61

$6.55

arrow_drop_up1.47%$0.09

Performance History

Key Stats
Open	$6.51
Prev. Close	$6.46
EPS	-0.08
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	6.45	6.67
52 Week Range	3.80	9.87

Ratios







EPS	-0.08

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Cytek Biosciences (CTKB)

Cytek Biosciences, Inc. (CTKB) is a leading provider of advanced flow cytometry systems and solutions for life science research. The company offers a wide range of innovative instruments and applications that empower scientists to unravel the complexities of the cellular universe. With its cutting-edge technology and user-friendly design, Cytek Biosciences is revolutionizing the field of flow cytometry and enabling breakthrough discoveries in fields such as immunology, cancer research, stem cell biology, and drug development.

One of the key strengths of Cytek Biosciences is its commitment to delivering high-quality, cost-effective solutions that meet the needs of researchers worldwide. The company's flagship product, the Cytek Aurora, is a multi-channel flow cytometer that provides exceptional performance and flexibility at an affordable price. With its unique spectral technology, the Cytek Aurora enables simultaneous detection of more than 40 colors, allowing researchers to analyze complex cellular processes with unprecedented precision and sensitivity.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Wenbin Jiang Ph.D.
Headquarters: Fremont
Employees: 699
Exchange: NASDAQ

Keep an eye on Cytek Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Cytek Biosciences's (CTKB) price per share?

The current price per share for Cytek Biosciences (CTKB) is $6.55. The stock has seen a price change of $0.09 recently, indicating a 1.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Cytek Biosciences (CTKB)?

For Cytek Biosciences (CTKB), the 52-week high is $9.87, which is 50.69% from the current price. The 52-week low is $3.8, the current price is 72.37% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Cytek Biosciences (CTKB) a growth stock?

Cytek Biosciences (CTKB) has shown an average price growth of -3.66% over the past three years. It has received a score of 16 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cytek Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Cytek Biosciences (CTKB) stock price performance year to date (YTD)?

As of the latest data, Cytek Biosciences (CTKB) has a year-to-date price change of -26.16%. Over the past month, the stock has experienced a price change of 35.05%. Over the last three months, the change has been 15.93%. Over the past six months, the figure is 10.64%.

help

Is Cytek Biosciences (CTKB) a profitable company?

Cytek Biosciences (CTKB) has a net income of -$12.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.69% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8.25% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $193.02M, with a revenue growth rate of 17.67%, providing insight into the company's sales performance and growth. The gross profit is $109.43M. Operating income is noted at -$27.84M. Furthermore, the EBITDA is -$15.16M.

help

What is the market capitalization of Cytek Biosciences (CTKB)?

Cytek Biosciences (CTKB) has a market capitalization of $843.71M. The average daily trading volume is 6.57, indicating the stock's liquidity and investor engagement.